Pathology

Researchers investigated how pathological assessments were affected by an AI tool trained to quantify tumor-infiltrating lymphocytes

The technology uses advanced optical techniques with AI-based deep learning algorithm to create realistic, virtually stained 3D images of cancer tissue without serial sectioning nor staining

The Molecular EQA program ensures that biomarker testing meets the highest standards of accuracy and reliability, supporting proficiency testing as an important part of medical laboratory practice

Join Today's Clinical Lab and speakers Nathan Buchbinder, Dr. Bilal R. Ahmad, Dr. Derek Welch, and Dr. Brian Rubin as they discuss survey insights on pathology’s transformation to AI and precision medicine

The three papers outline roles and required skills for bioinformaticians with respect to molecular diagnostics, clinical bioinformatics, clinical laboratory regulation, and data security

First blood-based in vitro diagnostic test to receive FDA clearance to help identify patients with amyloid pathology associated with Alzheimer’s disease

Even small tissue samples can yield additional insights into a tumor’s biology, immune interactions, and molecular pathways

CMO Eric E. Walk, MD, FCAP, shares insights about digital and AI pathology implementation in medical laboratories

Recent new and emerging technologies in the field of laboratory medicine from the 2025 April Cancer & Precision Medicine issue of Today's Clinical Lab

The customized solution enables the team to make informed variant interpretations and treatment recommendations

Digital slides can address problems that result in wasted time, caseload back-up, and diagnostic delays

AI and clinical data can also help laboratories maximize the potential of precision medicine

Reduce turnaround time, enhance diagnostic accuracy, and minimize manual labor in immunohistochemistry

Company to commercialize PanCystPro, including establishing an early access program and completing a clinical utility trial in 2025

Becton Dickinson’s plans will shift the IVD market and possibly create a stronger contender

Chief Medical Officer Deborah Sesok-Pizzini discusses digital pathology challenges and opportunities 

New resource from the National Comprehensive Cancer Network outlines how and why to access genetic counseling and testing for multiple hereditary cancers

The problem is that many medical reports aren’t written with patients in mind

C. Ola Landgren and colleagues discuss adapting to a field transformed by new immunotherapy drugs and targeted therapies and how to best combine treatments

Two clinical trials testing loncastuximab tesirine in patients with high-risk follicular lymphoma or with rare, marginal zone lymphoma show encouraging results